Read + Share
Padovani A, Caratozzolo S, Rozzini L, Pilotto A, et al. "Real-world" eligibility for aducanumab depends on clinical setting and patients'
journey. J Am Geriatr Soc 2022;70:626-628.
PMID: 34750815
|
 |
|
Padovani A, Caratozzolo S, Rozzini L, Pilotto A, et al. "Real-world" eligibility for aducanumab depends on clinical setting and patients'
journey. J Am Geriatr Soc 2022;70:626-628.
PMID: 34750815
|
|
|
|